GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mouse aurora a (ASN186->gly, LYS240->arg, MET302- >leu) in complex with 1-{5-[2-(1-methyl-1H-PYRAZOLO[4,3-D]PYRIMIDIN- 7-ylamino)-ethyl]-thiazol-2-yl}-3-(3-trifluoromethyl-phenyl)-urea

Analyse Crystal structure of mouse aurora a (ASN186->gly, LYS240->arg, MET302- >leu) in… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3D2I
Type
protein
Length
255 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE kinase 6
EC
2.7.11.1
UniProt
Q8C3H8
Ligands
AK3
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE kinase 6 (EC 2.7.11.1)protein25539% helix, 20% strandQ8C3H8

Ligands and binding sites

  • AK3 · 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14270.730.8242AK3
2710.380.7814empty

Compared structures

  • 3D2I · Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.